Cidara Therapeutics (CDTX) announced that Frank Karbe, MBA, has been appointed Chief Financial Officer, CFO, effective February 24, 2025. Karbe will succeed Preetam Shah, Ph.D., MBA, who is departing to pursue other professional opportunities. Dr. Shah will serve as a consultant to the Company.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDTX:
- Cidara Therapeutics assumed with an Overweight at Cantor Fitzgerald
- Cidara Therapeutics Announces Leadership Changes and Appointments
- Biotech Alert: Searches spiking for these stocks today
- Cidara Therapeutics files to sell 7.04M shares of common stock for holders
- Twelve option delistings on December 23rd